Biotech · Public company · Framingham, MA, US

Pulmatrix, Inc.

Ticker PULM · SEC CIK 0001574235

Track this companyFree. Adds Pulmatrix, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials30 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline3

Itraconazole PowderPhase 2 · ABPAClinicalTrials.gov · fetched Nov 12, 2026
PUR1900Phase 2 · Allergic Bronchopulmonary AspergillosisClinicalTrials.gov · fetched Nov 12, 2026
RUT058-60Phase 2 · Postoperative Wound Infection-deepClinicalTrials.gov · fetched Nov 12, 2026

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPAPHASE2 · TERMINATED · started Feb 1, 2023ClinicalTrials.gov NCT05667662 · fetched Nov 12, 2026
Study in Adult Asthmatic Patients With Allergic Bronchopulmonary AspergillosisPHASE2 · TERMINATED · started Jul 31, 2019ClinicalTrials.gov NCT03960606 · fetched Nov 12, 2026
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60PHASE1_PHASE2 · TERMINATED · started Oct 1, 2014ClinicalTrials.gov NCT02280395 · fetched Nov 12, 2026